Orchestra BioMed Holdings Inc. (NASDAQ: OBIO)
$8.47
-0.0600 ( -0.70% ) 105.0K
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
Market Data
Open
$8.47
Previous close
$8.53
Volume
105.0K
Market cap
$304.56M
Day range
$8.17 - $8.75
52 week range
$4.22 - $11.69
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 34 | Oct 10, 2023 |
3 | Insider transactions | 2 | Sep 29, 2023 |
3 | Insider transactions | 1 | Sep 22, 2023 |
8-k | 8K-related | 25 | Sep 19, 2023 |
10-q | Quarterly Reports | 88 | Aug 10, 2023 |
4 | Insider transactions | 1 | Jul 24, 2023 |
4 | Insider transactions | 1 | Jul 24, 2023 |
4 | Insider transactions | 1 | Jul 24, 2023 |
4 | Insider transactions | 1 | Jul 24, 2023 |
4 | Insider transactions | 1 | Jul 24, 2023 |